CACNA1C and heart disorder: Significantly, we found that EGT treatment downregulated intestinal Cacna1c expression and substantially reduced the abundance of the pathobiont Candidatus_Soleaferrea, a microorganism clinically associated with intestinal inflammation, cardiac diseases, and postoperative delirium [20, 30, 31].